A recent in vitro pilot investigation reported Rituximab significantly reduced natural killer (NK) cell cytotoxicity in healthy donors. Chronic fatigue syndrome/Myalgic encephalomyelitis (CFS/ME) is a debilitating disorder of unknown etiology. | Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients: A pilot in vitro investigation